Legal Representation
Attorney
Christopher D. Olszyk, Jr.
USPTO Deadlines
Next Deadline
9 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
August 13, 2025
Extension Available
Until August 13, 2025
Application History
18 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 13, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 13, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Feb 13, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Feb 12, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 13, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jun 18, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 18, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 29, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
May 9, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 9, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
May 8, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
May 8, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 1, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Apr 1, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Apr 1, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 29, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Dec 20, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Nov 18, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Diagnostic reagents, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
Class 005
Research use only chemical reagents for clinical medical or veterinary purposes; diagnostic reagents for medicinal research use
Class 010
Research use only biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; Research use only cancer screening tests and devices, namely, medical devices for evaluating immunotherapy cancer treatment options; Research use only cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; Research use only medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patient
Class 042
Providing reagent sample testing and diagnostic services for others in the field of cancer testing research, tumor testing research, and screening for the purpose of evaluating patient immunotherapy cancer treatment options
Classification
International Classes
001
005
010
042